OZEM vs. HTEC ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to Robo Global Healthcare Technology and Innovation ETF (HTEC)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$27.29
Average Daily Volume
32,886
14
HTEC
Robo Global Healthcare Technology and Innovation ETF
HTEC Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies products and services. It is non-diversified.Grade (RS Rating)
Last Trade
$29.81
Average Daily Volume
4,753
55
Performance
Period | OZEM | HTEC |
---|---|---|
30 Days | -6.06% | 3.60% |
60 Days | -1.68% | 5.01% |
90 Days | -0.63% | 4.45% |
12 Months | 28.07% |
1 Overlapping Holdings
Symbol | Grade | Weight in OZEM | Weight in HTEC | Overlap | |
---|---|---|---|---|---|
REGN | F | 2.39% | 1.15% | 1.15% |
OZEM Underweight 54 Positions Relative to HTEC
Symbol | Grade | Weight | |
---|---|---|---|
ILMN | A | -2.04% | |
AXGN | D | -1.97% | |
NTRA | C | -1.88% | |
ISRG | A | -1.87% | |
PEN | C | -1.87% | |
INCY | A | -1.86% | |
VRTX | B | -1.83% | |
RVTY | C | -1.79% | |
SYK | B | -1.76% | |
BSX | B | -1.75% | |
CRL | D | -1.72% | |
GH | C | -1.7% | |
CRSP | C | -1.7% | |
IRTC | C | -1.69% | |
VCYT | B | -1.65% | |
DHR | F | -1.61% | |
AORT | B | -1.6% | |
STAA | F | -1.59% | |
MASI | B | -1.58% | |
TMO | F | -1.57% | |
EXAS | F | -1.57% | |
CTLT | D | -1.54% | |
TWST | C | -1.53% | |
A | C | -1.49% | |
BIO | B | -1.48% | |
EW | F | -1.48% | |
ARWR | D | -1.46% | |
IART | C | -1.46% | |
OMCL | B | -1.45% | |
ABT | C | -1.45% | |
QGEN | C | -1.45% | |
NVCR | C | -1.42% | |
AZTA | F | -1.41% | |
BMY | B | -1.4% | |
MEDP | D | -1.39% | |
NOVT | B | -1.38% | |
GEHC | D | -1.38% | |
IQV | F | -1.37% | |
UTHR | A | -1.36% | |
ALGN | F | -1.31% | |
FLGT | C | -1.3% | |
GKOS | B | -1.29% | |
BDX | F | -1.27% | |
GMED | B | -1.26% | |
HOLX | D | -1.25% | |
DXCM | F | -1.24% | |
MRNA | F | -1.2% | |
CNMD | C | -1.14% | |
CDNA | D | -1.1% | |
VEEV | B | -1.1% | |
HCAT | C | -0.96% | |
BAX | F | -0.95% | |
BMRN | F | -0.93% | |
ALNY | C | -0.92% |
OZEM: Top Represented Industries & Keywords
HTEC: Top Represented Industries & Keywords